A substantial body of work has demonstrated that the abnormal expression of the Smad3 gene is an important pathogenic mechanism in diseases such as hepatic, renal, and pulmonary fibrosis [4–6]. This evidence concerns the gene SMAD3 and pulmonary fibrosis.